Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW842166X for pre-emptive analgesia after third molar extraction
2006-002691-18Phase 2Terminated
- Sponsor
- GSK
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of GW842166 in Inflammatory pain is not a disease; it is a symptom or type of pain associated with various inflammatory conditions and odontalgia (4 arms), sponsored by GSK. Primary endpoint: Weighted mean pain intensity over 10 hours post-dose. Started Sep 2006; status: terminated.
02
Drugs
GW842166
03
Conditions
Inflammatory pain is not a disease; it is a symptom or type of pain associated with various inflammatory conditions.odontalgia
Beyond the preview
Go deeper on 2006-002691-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002691-18.